183 related articles for article (PubMed ID: 10912888)
1. Effect of rhEPO administration on serum levels of sTfR and cycling performance.
Birkeland KI; Stray-Gundersen J; Hemmersbach P; Hallen J; Haug E; Bahr R
Med Sci Sports Exerc; 2000 Jul; 32(7):1238-43. PubMed ID: 10912888
[TBL] [Abstract][Full Text] [Related]
2. Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.
Wilber RL
Sports Med; 2002; 32(2):125-42. PubMed ID: 11817997
[TBL] [Abstract][Full Text] [Related]
3. Serum sTfR levels may indicate charge profiling of urinary r-hEPO in doping control.
Nissen-Lie G; Birkeland K; Hemmersbach P; Skibeli V
Med Sci Sports Exerc; 2004 Apr; 36(4):588-93. PubMed ID: 15064585
[TBL] [Abstract][Full Text] [Related]
4. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
[TBL] [Abstract][Full Text] [Related]
5. Effects of erythropoietin administration in training athletes and possible indirect detection in doping control.
Audran M; Gareau R; Matecki S; Durand F; Chenard C; Sicart MT; Marion B; Bressolle F
Med Sci Sports Exerc; 1999 May; 31(5):639-45. PubMed ID: 10331881
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy.
Biesma DH; Van de Wiel A; Beguin Y; Kraaijenhagen RJ; Marx JJ
Eur J Clin Invest; 1994 Jun; 24(6):426-32. PubMed ID: 7957497
[TBL] [Abstract][Full Text] [Related]
8. Optimal timing of repeated rh-erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers.
Breymann C; Bauer C; Major A; Zimmermann R; Gautschi K; Huch A; Huch R
Br J Haematol; 1996 Feb; 92(2):295-301. PubMed ID: 8602988
[TBL] [Abstract][Full Text] [Related]
9. Effects of exercise on soluble transferrin receptor and other variables of the iron status.
Schumacher YO; Schmid A; König D; Berg A
Br J Sports Med; 2002 Jun; 36(3):195-9. PubMed ID: 12055114
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men.
Berglund B; Ekblom B
J Intern Med; 1991 Feb; 229(2):125-30. PubMed ID: 1997637
[TBL] [Abstract][Full Text] [Related]
11. Echinacea-Based Dietary Supplement Does Not Increase Maximal Aerobic Capacity in Endurance-Trained Men and Women.
Stevenson JL; Krishnan S; Inigo MM; Stamatikos AD; Gonzales JU; Cooper JA
J Diet Suppl; 2016; 13(3):324-38. PubMed ID: 26317662
[TBL] [Abstract][Full Text] [Related]
12. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
Wang W; Zhang MH; Yu Y; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
[TBL] [Abstract][Full Text] [Related]
13. Influence of recombinant human erythropoietin treatment on pulmonary O2 uptake kinetics during exercise in humans.
Wilkerson DP; Rittweger J; Berger NJ; Naish PF; Jones AM
J Physiol; 2005 Oct; 568(Pt 2):639-52. PubMed ID: 16081477
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes.
Stein RS; Abels RI; Krantz SB
Blood; 1991 Oct; 78(7):1658-63. PubMed ID: 1912554
[TBL] [Abstract][Full Text] [Related]
15. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes.
Parisotto R; Gore CJ; Emslie KR; Ashenden MJ; Brugnara C; Howe C; Martin DT; Trout GJ; Hahn AG
Haematologica; 2000 Jun; 85(6):564-72. PubMed ID: 10870111
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.
Kuo CC; Lee CT; Chuang CH; Su Y; Chen JB
Clin Nephrol; 2005 Feb; 63(2):92-7. PubMed ID: 15730050
[TBL] [Abstract][Full Text] [Related]
17. Serum transferrin receptor, ferritin, and reticulocyte maturity indices during the first year of life in 'large' preterm infants.
Schiza V; Giapros V; Pantou K; Theocharis P; Challa A; Andronikou S
Eur J Haematol; 2007 Nov; 79(5):439-46. PubMed ID: 17916083
[TBL] [Abstract][Full Text] [Related]
18. Soluble transferrin receptor as a marker of erythropoiesis in patients undergoing high-flux hemodialysis.
Yin P; Song Y; Li J
Bosn J Basic Med Sci; 2017 Nov; 17(4):333-338. PubMed ID: 28446125
[TBL] [Abstract][Full Text] [Related]
19. Comparative response of EPO and soluble transferrin receptor at high altitude.
Robach P; Fulla Y; Westerterp KR; Richalet JP
Med Sci Sports Exerc; 2004 Sep; 36(9):1493-8; discussion 1492. PubMed ID: 15354029
[TBL] [Abstract][Full Text] [Related]
20. Soluble transferrin receptor concentration is not superior to log ferritin for evaluating erythropoiesis in adolescents with iron deficiency anemia.
Choi JW; Son BK
Clin Chim Acta; 2005 May; 355(1-2):83-9. PubMed ID: 15820481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
